Hua Yu

Hua Yu

Auto-generated profile, based on publicly available information

Hua Yu

Institute of Clinical Immunology, Yue-Yang Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XLXiaojun Liu
Xiaojun Liu
JMJinyun Ma
Jinyun Ma
GDGuiqing Ding
Guiqing Ding
QGQianyi Gong
Qianyi Gong
YWYuanhua Wang
Yuanhua Wang
XCXiaodong Cheng
Xiaodong Cheng
Activated microglia is considered to be major mediators of the neuroinflammatory environment in demyelinating diseases of the central nervous system (CNS). Activated microglia are mainly polarized into M1 type, which plays a role in promoting inflammation and demyelinating. However, the proportion of microglia polarized into M2 type is relatively low, which cannot fully play the role of anti‐inflammatory and resistance to demyelinating. Our previous study found that Astragalus polysaccharides (APS) has an immunomodulatory effect and can inhibit neuroinflammation and demyelination in experimental autoimmune encephalomyelitis (EAE), which is a classic animal model of CNS demyelinating disease. In this study, we found that APS was effective in treating EAE mice. It restored microglia balance by inhibiting the polarization of microglia to M1‐like phenotype and promoting the polarization of microglia to M2‐like phenotype in vivo and in vitro. miR‐155 is a key factor in regulating microglia polarization. We found that APS could inhibit the expression level of miR‐155 in vivo and in vitro. Furthermore, we performed transfection overexpression and blocking experiments. The results showed that miR‐155 mediated the polarization of microglia M1/M2 phenotype, while the selective inhibitor of miR‐155 attenuated the inhibition of APS on microglia M1 phenotype and eliminated the promotion of APS on microglia M2 phenotype. Microglia can secrete IL‐1α, TNF‐α, and C1q after polarizing into M1 type and induce the activation of A1 neurotoxic astrocytes, further aggravating neuroinflammation and demyelination. APS reduced the secretion of IL‐1α, TNF‐α, and C1q by activated microglia, thus inhibited the formation of A1 neurotoxic astrocytes. In summary, our study suggests that APS regulates the polarization of microglia from M1 to M2 phenotype by inhibiting the miR‐155, reduces the secretion of inflammatory factors, and inhibits the activation of neurotoxic astrocytes, thus effectively treating EAE.

3 December 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
YZYan Zhao
Yan Zhao
JMJinyun Ma
Jinyun Ma
GDGuiqing Ding
Guiqing Ding
YWYuanhua Wang
Yuanhua Wang
HYHua Yu
Hua Yu
XCXiaodong Cheng
Xiaodong Cheng